Annual Health Screenings Men Often Skip — and Why They Matter

Hypertension — high blood pressure — affects roughly one in three adult men in the United States, yet nearly a third of those with the condition are unaware they have it. It produces no pain, no visible symptoms, and no warning signs until damage to the heart, kidneys, or arteries is already underway.

The U.S. Preventive Services Task Force (USPSTF) recommends blood pressure screening for all adults aged 18 and older. For men with readings in the normal range, annual or biennial checks are typically sufficient. Those with elevated readings or additional risk factors may need more frequent monitoring. High blood pressure is a leading modifiable risk factor for heart disease — the number one cause of death among men. See our overview of cardiovascular disease risk in men for context on how these factors interact.

A lipid panel measures total cholesterol, LDL (low-density lipoprotein), HDL (high-density lipoprotein), and triglycerides. Abnormal levels — particularly elevated LDL — are a primary driver of atherosclerosis, the progressive narrowing of arteries that underlies most heart attacks and strokes.

Men aged 35 and older are generally advised to have cholesterol checked routinely. Younger men with risk factors such as obesity, smoking, diabetes, or a family history of early heart disease may benefit from earlier testing. A single elevated reading doesn't automatically mean medication — lifestyle changes are frequently the first line of management — but you need a test to know where you stand.

Type 2 diabetes develops gradually, often over years, during which blood glucose levels are elevated enough to cause organ damage but not high enough to produce obvious symptoms. The USPSTF recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 who are overweight or have obesity.

A fasting plasma glucose test or HbA1c (glycated hemoglobin) test — which reflects average blood sugar over roughly three months — are the standard approaches. Men with a sedentary lifestyle, a family history of diabetes, or high blood pressure face elevated risk and may warrant earlier or more frequent testing. Unmanaged diabetes significantly raises the risk of cardiovascular disease, kidney failure, and nerve damage.

Colorectal cancer is the second leading cause of cancer death in men in the United States. It is also among the most preventable: screening can identify precancerous polyps before they become malignant. Despite this, screening rates among eligible men remain well below recommended targets.

Current guidelines from major US health bodies generally recommend that average-risk adults begin colorectal cancer screening at age 45. Options range from a colonoscopy every ten years to less invasive stool-based tests performed more frequently. Men with a family history of colorectal cancer or inflammatory bowel disease may need to start earlier. Discuss the right interval and method with your provider based on your personal history.

Men are disproportionately affected by melanoma — the deadliest form of skin cancer — and are significantly less likely than women to apply sunscreen or attend skin checks. The biological and behavioural factors behind this gap are well documented, and the outcome gap is stark: men are more likely to be diagnosed at a later stage, when treatment is more complex.

A full-body skin examination by a dermatologist can identify suspicious lesions, atypical moles, and early-stage melanomas that are difficult to detect through self-examination alone. While universal screening intervals haven't been standardised in the same way as other tests, men with a history of sun exposure, fair skin, a large number of moles, or a personal or family history of skin cancer should discuss annual skin checks with their provider. For a detailed look at the risk picture, see skin cancer risk in men.

The PSA test measures a protein produced by the prostate gland. Elevated levels can indicate prostate cancer, though they can also reflect non-cancerous conditions such as benign prostatic hyperplasia or prostatitis. This makes the test a starting point for investigation, not a definitive diagnosis.

Screening recommendations for PSA testing are more nuanced than for other screenings. Major health organisations generally recommend that men at average risk discuss the benefits and limitations of PSA testing with their doctor starting around age 50. Men of African descent and those with a first-degree relative diagnosed with prostate cancer before age 65 face higher risk and may want to begin this conversation earlier — typically around age 40 to 45. Urinary changes can sometimes accompany prostate issues; recognising urinary symptoms worth reporting covers the patterns that warrant professional attention.

Osteoporosis is widely perceived as a women's health issue — but approximately one in four men over the age of 50 will experience an osteoporosis-related fracture in their lifetime. Male bone loss is less studied and often diagnosed later, partly because routine screening in men is less consistently recommended and less frequently discussed.

A dual-energy X-ray absorptiometry (DEXA) scan measures bone mineral density and assesses fracture risk. Men aged 70 and older, or younger men with significant risk factors — including long-term corticosteroid use, hypogonadism, heavy alcohol use, or a history of fractures — are generally considered candidates for screening. For a fuller picture of how bone density changes with age in men, see our piece on male bone density and osteoporosis risk.